S

Structure Therapeutics Inc
NASDAQ:GPCR

Watchlist Manager
Structure Therapeutics Inc
NASDAQ:GPCR
Watchlist
Price: 23.86 USD -2.81% Market Closed
Market Cap: 1.4B USD

Intrinsic Value

GPCR's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one GPCR stock under the Base Case scenario is 15.41 USD. Compared to the current market price of 23.86 USD, Structure Therapeutics Inc is Overvalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GPCR Intrinsic Value
15.41 USD
Overvaluation 35%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Structure Therapeutics Inc

Valuation History Unavailable

Historical valuation for GPCR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Structure Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Structure Therapeutics Inc

Current Assets 891.2m
Cash & Short-Term Investments 883.5m
Other Current Assets 7.7m
Non-Current Assets 12.1m
PP&E 7m
Other Non-Current Assets 5.1m
Efficiency

Free Cash Flow Analysis
Structure Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Structure Therapeutics Inc

Revenue
0 USD
Operating Expenses
-158.2m USD
Operating Income
-158.2m USD
Other Expenses
35.7m USD
Net Income
-122.5m USD
Fundamental Scores

GPCR Profitability Score
Profitability Due Diligence

Structure Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

28/100
Profitability
Score

Structure Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

GPCR Solvency Score
Solvency Due Diligence

Structure Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Structure Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GPCR Price Targets Summary
Structure Therapeutics Inc

Wall Street analysts forecast GPCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GPCR is 80.29 USD with a low forecast of 50.5 USD and a high forecast of 123.9 USD.

Lowest
Price Target
50.5 USD
112% Upside
Average
Price Target
80.29 USD
236% Upside
Highest
Price Target
123.9 USD
419% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Structure Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GPCR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GPCR Insider Trading
Buy and sell transactions by insiders

GPCR News

Other Videos
What is the Intrinsic Value of one GPCR stock?

The intrinsic value of one GPCR stock under the Base Case scenario is 15.41 USD.

Is GPCR stock undervalued or overvalued?

Compared to the current market price of 23.86 USD, Structure Therapeutics Inc is Overvalued by 35%.

Back to Top